Goldman Sachs analyst Jamie Perse maintains Universal Health Servs (NYSE:UHS) with a Buy and raises the price target from $200 to $229.
Goldman Sachs Maintains Buy on Universal Health Servs, Raises Price Target to $229
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.